HIV trials recruiting in Illinois

All HIV trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
  NCT07266831 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · Illinois: Chicago
• A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
  NCT07392372 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Illinois: Chicago
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Illinois: Chicago
• A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
  NCT07202546 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
  NCT04139304 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
  NCT06206564 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV
  NCT07502365 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 35 Years · Sex: All (male and female) · Illinois: Chicago
• Case Management Dyad
  NCT06162897 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Dasatinib for HIV-1 Reservoir Reduction
  NCT07342491 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men
  NCT05678556 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 34 Years · Sex: All (male and female) · Illinois: Chicago
• Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
  NCT06071767 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
  NCT06139224 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
  NCT05723653 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 49 Years · Sex: All (male and female) · Illinois: Chicago
• IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
  NCT06266416 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years and older · Sex: All (male and female) · Illinois: Chicago
• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
  NCT05077527 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
  NCT07473778 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
  NCT06477588 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention
  NCT05848570 · Phase: Not specified · Ages: 13 Years to 34 Years · Sex: All (male and female) · Illinois: Chicago
• Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
  NCT06263426 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Menopausal HT for Women Living With HIV (HoT)
  NCT06856174 · Phase: Phase 4 · Ages: 40 Years to 60 Years · Sex: Female · Illinois: Chicago
• MyPEEPS LITE Trial
  NCT06741631 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 29 Years · Sex: Male · Illinois: Chicago
• Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
  NCT07040319 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 45 Years · Sex: Female · Illinois: Chicago
• The Trans-Led Care Study
  NCT06880705 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Trial of Ixazomib for Kaposi Sarcoma
  NCT04305691 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
  NCT07293559 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Illinois: Chicago
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · Illinois: Chicago
• Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority Men
  NCT06894199 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago